Market Research Logo

Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services

Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services]}, Clinical Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology & Hepatology, Ophthalmology), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Japan, India, China, Brazil, Mexico, Saudi Arabia, South Africa), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Contract Research Organization (CRO) Market will exceed USD 56.5 billion by 2024; as per a new research report.

Growing trend of technological advances coupled with pharmacovigilance outsourcing will drive the contract research organization market growth over the forecast timeline. Implementation of technologies such as patient recorded outcomes (PRO), clinical trial management systems (CTMS) and electronic data capture (EDC) further favors contract research organization industry growth. Regulations focusing on enhancing patient safety and quality management systems should boost CRO market growth over the coming years.

Rising prevalence of chronic ailments such as infectious diseases, cancer further fosters business growth. Larger commercialization of R&D in drug industry can boost productivity that should drive contract research organization (CRO) market. Moreover, increasing demand for global clinical trials and requirement for quality auditing will augment CRO industry growth. However, intellectual property issues surface at numerous points in technology transfer and institutional research that can restrain contract research organization (CRO) market growth.

Early phase development services segment was valued at USD 5.8 billion in 2017 and is projected to grow significantly over the forecast timeframe. The growth is attributable to increasing early research activities in drug discovery process coupled with rising outsourcing for early phase development.

Cardiology segment will witness 8.1% CAGR by 2024 due to growing prevalence of cardiovascular diseases and surging number of clinical trials in cardiology. According to American Heart Association 2018 data nearly 92.1 million American adults are having after effects of stroke or some type of cardiovascular disease (CVD). Indirect and direct costs of overall CVDs and stroke are projected to exceed USD 329.7 billion. Rising adoption of unhealthy eating habits and lack of physical exercises accelerate the prevalence of CVD that should further boost segmental growth in forthcoming years.

Academic institutes segment accounted for 16.5% revenue share in 2017 owing to growing number of outsourcing research activities to academic institutes. Rapidly developing research practices coupled with rising outsourcing of R&D activities should spur segmental growth in foreseeable future.

U.S. CRO market will grow at 7.3% during the forecast timeframe due to technological advances and wide-ranging drug development activities conducted in the country. Additionally, presence of several pharma companies in the U.S. should render positive impact on CRO industry.

China CRO market was valued at USD 1.3 billion in 2017 and is estimated to experience considerable growth over the coming years. The growth is attributable to fast approval procedures. Chinese firms pursue transparent and fast approval procedures through results that are acceptable to U.S. FDA thereby, fosters business growth.

Some of the prominent competitors operating in CRO market include Charles River Laboratories International (CRL), Clinipace, Clinitec, CMIC, EPS International, ICON, Laboratory Corporation of America Holdings (Covance), Medpace, Parexel International, Pharmaceutical Product Development (PDD), LLC, PRA Health Sciences, IQVIA (Quintiles IMS), Syneos Health, Synteract, Worldwide Clinical Trials and Wuxi AppTec. Industry competitors are mainly focusing on inorganic strategies such as partnership, merger and acquisitions. Merger and acquisitions ensure cost savings in CRO operations. Additionally, it also strengthens their foothold in the CRO market and capture more revenue share.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Contract research organization industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Service type trends
2.1.3. Therapeutic area trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Contract Research Organization Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing R&D expenditure worldwide
3.3.1.2. Rising number of clinical trials in emerging economies
3.3.1.3. Growing outsourcing of R&D activities
3.3.1.4. Rising technological advancements
3.3.2. Industry pitfalls and challenges
3.3.2.1. Intellectual property rights issues
3.4. Growth potential analysis
3.4.1. By service type
3.4.2. By therapeutic area
3.4.3. By end-use
3.5. Regulatory landscape
3.6. Porter’s analysis
3.7. Competitive landscape, 2017
3.7.1. Company market share analysis, 2017
3.7.2. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. Contract Research Organization Market, By Service Type
4.1. Key segment trends
4.2. Early phase development services
4.2.1. Market size, by region, 2013 – 2024
4.2.2. Discovery services
4.2.2.1. Market size, by region, 2013 – 2024
4.2.3. Chemistry, manufacturing & control (CMC)
4.2.3.1. Market size, by region, 2013 – 2024
4.2.4. Pre-clinical services
4.2.4.1. Market size, by region, 2013 – 2024
4.2.4.2. Pharmacokinetics/pharmacodynamics (PK/PD)
4.2.4.2.1. Market size, by region, 2013 – 2024
4.2.4.3. Toxicology testing services
4.2.4.3.1. Market size, by region, 2013 – 2024
4.2.4.4. Others
4.2.4.4.1. Market size, by region, 2013 – 2024
4.3. Clinical research services
4.3.1. Market size, by region, 2013 – 2024
4.3.2. Phase I
4.3.2.1. Market size, by region, 2013 – 2024
4.3.3. Phase II
4.3.3.1. Market size, by region, 2013 – 2024
4.3.4. Phase III
4.3.4.1. Market size, by region, 2013 – 2024
4.3.5. Phase IV
4.3.5.1. Market size, by region, 2013 – 2024
4.4. Laboratory services
4.4.1. Market size, by region, 2013 – 2024
4.4.2. Bioanalytical testing services
4.4.2.1. Market size, by region, 2013 – 2024
4.4.3. Analytical testing services
4.4.3.1. Market size, by region, 2013 – 2024
4.4.3.2. Physical characterization
4.4.3.2.1. Market size, by region, 2013 – 2024
4.4.3.3. Raw material testing
4.4.3.3.1. Market size, by region, 2013 – 2024
4.4.3.4. Batch release testing
4.4.3.4.1. Market size, by region, 2013 – 2024
4.4.3.5. Stability testing
4.4.3.5.1. Market size, by region, 2013 – 2024
4.4.3.6. Others
4.4.3.6.1. Market size, by region, 2013 – 2024
4.5. Consulting services
4.5.1. Market size, by region, 2013 – 2024
Chapter 5. Contract Research Organization Market, By Therapeutic Area
5.1. Key segment trends
5.2. Oncology
5.2.1. Market size, by region, 2013 – 2024
5.3. Clinical pharmacology
5.3.1. Market size, by region, 2013 – 2024
5.4. Cardiology
5.4.1. Market size, by region, 2013 – 2024
5.5. Infectious disease
5.5.1. Market size, by region, 2013 – 2024
5.6. Neurology
5.6.1. Market size, by region, 2013 – 2024
5.7. Gastroenterology & hepatology
5.7.1. Market size, by region, 2013 – 2024
5.8. Ophthalmology
5.8.1. Market size, by region, 2013 – 2024
5.9. Others
5.9.1. Market size, by region, 2013 – 2024
Chapter 6. Contract Research Organization Market, By End-use
6.1. Key segment trends
6.2. Pharmaceutical & biopharmaceutical companies
6.2.1. Market size, by region, 2013 – 2024
6.3. Medical device companies
6.3.1. Market size, by region, 2013 – 2024
6.4. Academic institutes
6.4.1. Market size, by region, 2013 – 2024
Chapter 7. Contract Research Organization Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country 2013 – 2024
7.2.2. Market size, by service type, 2013 – 2024
7.2.2.1. Market size, by early phase development services, 2013 – 2024
7.2.2.1.1. Market size, by pre-clinical services, 2013 – 2024
7.2.2.2. Market size, by clinical research services, 2013 – 2024
7.2.2.3. Market size, by laboratory services, 2013 – 2024
7.2.2.3.1. Market size, by analytical testing services, 2013 – 2024
7.2.3. Market size, by therapeutic area, 2013 – 2024
7.2.4. Market size, by end-use, 2013 – 2024
7.2.5. U.S.
7.2.5.1. Market size, by service type, 2013 – 2024
7.2.5.1.1. Market size, by early phase development services, 2013 – 2024
7.2.5.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.2.5.1.2. Market size, by clinical research services, 2013 – 2024
7.2.5.1.3. Market size, by laboratory services, 2013 – 2024
7.2.5.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.2.5.2. Market size, by therapeutic area, 2013 – 2024
7.2.5.3. Market size, by end-use, 2013 – 2024
7.2.6. Canada
7.2.6.1. Market size, by service type, 2013 – 2024
7.2.6.1.1. Market size, by early phase development services, 2013 – 2024
7.2.6.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.2.6.1.2. Market size, by clinical research services, 2013 – 2024
7.2.6.1.3. Market size, by laboratory services, 2013 – 2024
7.2.6.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.2.6.2. Market size, by therapeutic area, 2013 – 2024
7.2.6.3. Market size, by end-use, 2013 – 2024
7.3. Europe
7.3.1. Market size, by country 2013 – 2024
7.3.2. Market size, by service type, 2013 – 2024
7.3.2.1. Market size, by early phase development services, 2013 – 2024
7.3.2.1.1. Market size, by pre-clinical services, 2013 – 2024
7.3.2.2. Market size, by clinical research services, 2013 – 2024
7.3.2.3. Market size, by laboratory services, 2013 – 2024
7.3.2.3.1. Market size, by analytical testing services, 2013 – 2024
7.3.3. Market size, by therapeutic area, 2013 – 2024
7.3.4. Market size, by end-use, 2013 – 2024
7.3.5. Germany
7.3.5.1. Market size, by service type, 2013 – 2024
7.3.5.1.1. Market size, by early phase development services, 2013 – 2024
7.3.5.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.3.5.1.2. Market size, by clinical research services, 2013 – 2024
7.3.5.1.3. Market size, by laboratory services, 2013 – 2024
7.3.5.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.3.5.2. Market size, by therapeutic area, 2013 – 2024
7.3.5.3. Market size, by end-use, 2013 – 2024
7.3.6. France
7.3.6.1. Market size, by service type, 2013 – 2024
7.3.6.1.1. Market size, by early phase development services, 2013 – 2024
7.3.6.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.3.6.1.2. Market size, by clinical research services, 2013 – 2024
7.3.6.1.3. Market size, by laboratory services, 2013 – 2024
7.3.6.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.3.6.2. Market size, by therapeutic area, 2013 – 2024
7.3.6.3. Market size, by end-use, 2013 – 2024
7.3.7. UK
7.3.7.1. Market size, by service type, 2013 – 2024
7.3.7.1.1. Market size, by early phase development services, 2013 – 2024
7.3.7.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.3.7.1.2. Market size, by clinical research services, 2013 – 2024
7.3.7.1.3. Market size, by laboratory services, 2013 – 2024
7.3.7.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.3.7.2. Market size, by therapeutic area, 2013 – 2024
7.3.7.3. Market size, by end-use, 2013 – 2024
7.3.8. Italy
7.3.8.1. Market size, by service type, 2013 – 2024
7.3.8.1.1. Market size, by early phase development services, 2013 – 2024
7.3.8.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.3.8.1.2. Market size, by clinical research services, 2013 – 2024
7.3.8.1.3. Market size, by laboratory services, 2013 – 2024
7.3.8.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.3.8.2. Market size, by therapeutic area, 2013 – 2024
7.3.8.3. Market size, by end-use, 2013 – 2024
7.3.9. Spain
7.3.9.1. Market size, by service type, 2013 – 2024
7.3.9.1.1. Market size, by early phase development services, 2013 – 2024
7.3.9.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.3.9.1.2. Market size, by clinical research services, 2013 – 2024
7.3.9.1.3. Market size, by laboratory services, 2013 – 2024
7.3.9.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.3.9.2. Market size, by therapeutic area, 2013 – 2024
7.3.9.3. Market size, by end-use, 2013 – 2024
7.4. Asia Pacific
7.4.1. Market size, by country 2013 – 2024
7.4.2. Market size, by service type, 2013 – 2024
7.4.2.1. Market size, by early phase development services, 2013 – 2024
7.4.2.1.1. Market size, by pre-clinical services, 2013 – 2024
7.4.2.2. Market size, by clinical research services, 2013 – 2024
7.4.2.3. Market size, by laboratory services, 2013 – 2024
7.4.2.3.1. Market size, by analytical testing services, 2013 – 2024
7.4.3. Market size, by therapeutic area, 2013 – 2024
7.4.4. Market size, by end-use, 2013 – 2024
7.4.5. Japan
7.4.5.1. Market size, by service type, 2013 – 2024
7.4.5.1.1. Market size, by early phase development services, 2013 – 2024
7.4.5.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.4.5.1.2. Market size, by clinical research services, 2013 – 2024
7.4.5.1.3. Market size, by laboratory services, 2013 – 2024
7.4.5.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.4.5.2. Market size, by therapeutic area, 2013 – 2024
7.4.5.3. Market size, by end-use, 2013 – 2024
7.4.6. India
7.4.6.1. Market size, by service type, 2013 – 2024
7.4.6.1.1. Market size, by early phase development services, 2013 – 2024
7.4.6.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.4.6.1.2. Market size, by clinical research services, 2013 – 2024
7.4.6.1.3. Market size, by laboratory services, 2013 – 2024
7.4.6.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.4.6.2. Market size, by therapeutic area, 2013 – 2024
7.4.6.3. Market size, by end-use, 2013 – 2024
7.4.7. China
7.4.7.1. Market size, by service type, 2013 – 2024
7.4.7.1.1. Market size, by early phase development services, 2013 – 2024
7.4.7.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.4.7.1.2. Market size, by clinical research services, 2013 – 2024
7.4.7.1.3. Market size, by laboratory services, 2013 – 2024
7.4.7.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.4.7.2. Market size, by therapeutic area, 2013 – 2024
7.4.7.3. Market size, by end-use, 2013 – 2024
7.5. Latin America
7.5.1. Market size, by country 2013 – 2024
7.5.2. Market size, by service type, 2013 – 2024
7.5.2.1. Market size, by early phase development services, 2013 – 2024
7.5.2.1.1. Market size, by pre-clinical services, 2013 – 2024
7.5.2.2. Market size, by clinical research services, 2013 – 2024
7.5.2.3. Market size, by laboratory services, 2013 – 2024
7.5.2.3.1. Market size, by analytical testing services, 2013 – 2024
7.5.3. Market size, by therapeutic area, 2013 – 2024
7.5.4. Market size, by end-use, 2013 – 2024
7.5.5. Brazil
7.5.5.1. Market size, by service type, 2013 – 2024
7.5.5.1.1. Market size, by early phase development services, 2013 – 2024
7.5.5.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.5.5.1.2. Market size, by clinical research services, 2013 – 2024
7.5.5.1.3. Market size, by laboratory services, 2013 – 2024
7.5.5.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.5.5.2. Market size, by therapeutic area, 2013 – 2024
7.5.5.3. Market size, by end-use, 2013 – 2024
7.5.6. Mexico
7.5.6.1. Market size, by service type, 2013 – 2024
7.5.6.1.1. Market size, by early phase development services, 2013 – 2024
7.5.6.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.5.6.1.2. Market size, by clinical research services, 2013 – 2024
7.5.6.1.3. Market size, by laboratory services, 2013 – 2024
7.5.6.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.5.6.2. Market size, by therapeutic area, 2013 – 2024
7.5.6.3. Market size, by end-use, 2013 – 2024
7.6. MEA
7.6.1. Market size, by country 2013 – 2024
7.6.2. Market size, by service type, 2013 – 2024
7.6.2.1. Market size, by early phase development services, 2013 – 2024
7.6.2.1.1. Market size, by pre-clinical services, 2013 – 2024
7.6.2.2. Market size, by clinical research services, 2013 – 2024
7.6.2.3. Market size, by laboratory services, 2013 – 2024
7.6.2.3.1. Market size, by analytical testing services, 2013 – 2024
7.6.3. Market size, by therapeutic area, 2013 – 2024
7.6.4. Market size, by end-use, 2013 – 2024
7.6.5. Saudi Arabia
7.6.5.1. Market size, by service type, 2013 – 2024
7.6.5.1.1. Market size, by early phase development services, 2013 – 2024
7.6.5.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.6.5.1.2. Market size, by clinical research services, 2013 – 2024
7.6.5.1.3. Market size, by laboratory services, 2013 – 2024
7.6.5.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.6.5.2. Market size, by therapeutic area, 2013 – 2024
7.6.5.3. Market size, by end-use, 2013 – 2024
7.6.6. South Africa
7.6.6.1. Market size, by service type, 2013 – 2024
7.6.6.1.1. Market size, by early phase development services, 2013 – 2024
7.6.6.1.1.1. Market size, by pre-clinical services, 2013 – 2024
7.6.6.1.2. Market size, by clinical research services, 2013 – 2024
7.6.6.1.3. Market size, by laboratory services, 2013 – 2024
7.6.6.1.3.1. Market size, by analytical testing services, 2013 – 2024
7.6.6.2. Market size, by therapeutic area, 2013 – 2024
7.6.6.3. Market size, by end-use, 2013 – 2024
Chapter 8. Company Profiles
8.1. Charles River Laboratories International, Inc. (CRL)
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Clinipace
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Clinitec
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. CMIC Holdings Co., Ltd
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. EPS International
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. ICON Public Limited Corporation
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Laboratory Corporation of America Holdings (Covance Inc.)
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Medpace, Inc.
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Parexel International Corporation
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Pharmaceutical Product Development (PDD), LLC.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. PRA Health Sciences
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
8.12. IQVIA (Quintiles IMS Holdings, Inc.)
8.12.1. Business overview
8.12.2. Financial data
8.12.3. Product landscape
8.12.4. Strategic outlook
8.12.5. SWOT analysis
8.13. Syneos Health
8.13.1. Business overview
8.13.2. Financial data
8.13.3. Product landscape
8.13.4. Strategic outlook
8.13.5. SWOT analysis
8.14. Synteract
8.14.1. Business overview
8.14.2. Financial data
8.14.3. Product landscape
8.14.4. Strategic outlook
8.14.5. SWOT analysis
8.15. Worldwide Clinical Trials
8.15.1. Business overview
8.15.2. Financial data
8.15.3. Product landscape
8.15.4. Strategic outlook
8.15.5. SWOT analysis
8.16. Wuxi AppTec
8.16.1. Business overview
8.16.2. Financial data
8.16.3. Product landscape
8.16.4. Strategic outlook
8.16.5. SWOT analysis
Data Tables
TABLE 1 CRO industry 360º synopsis, 2013 – 2024
TABLE 2 CRO, 2013-2017 (USD Million)
TABLE 3 CRO market, 2018-2024 (USD Million)
TABLE 4 CRO market, by service type, 2013-2017 (USD Million)
TABLE 5 CRO market, by service type, 2018-2024 (USD Million)
TABLE 6 CRO market, by therapeutic area, 2013-2017 (USD Million)
TABLE 7 CRO market, by therapeutic area, 2018-2024 (USD Million)
TABLE 8 CRO market, by end-use, 2013-2017 (USD Million)
TABLE 9 CRO market, by end-use, 2018-2024 (USD Million)
TABLE 10 CRO market, by region, 2013-2017 (USD Million)
TABLE 11 CRO market, by region, 2018-2024 (USD Million)
TABLE 12 Industry impact forces
TABLE 13 Early phase development services market size, by region, 2013-2017 (USD Million)
TABLE 14 Early phase development services market size, by region, 2018-2024 (USD Million)
TABLE 15 Discovery services market size, by region, 2013-2017 (USD Million)
TABLE 16 Discovery services market size, by region, 2018-2024 (USD Million)
TABLE 17 CMC market size, by region, 2013-2017 (USD Million)
TABLE 18 CMC market size, by region, 2018-2024 (USD Million)
TABLE 19 Pre-clinical services market size, by region, 2013-2017 (USD Million)
TABLE 20 Pre-clinical services market size, by region, 2018-2024 (USD Million)
TABLE 21 PK/PD market size, by region, 2013-2017 (USD Million)
TABLE 22 PK/PD market size, by region, 2018-2024 (USD Million)
TABLE 23 Toxicology testing services market size, by region, 2013-2017 (USD Million)
TABLE 24 Toxicology testing services market size, by region, 2018-2024 (USD Million)
TABLE 25 Others market size, by region, 2013-2017 (USD Million)
TABLE 26 Others market size, by region, 2018-2024 (USD Million)
TABLE 27 Clinical research services market size, by region, 2013-2017 (USD Million)
TABLE 28 Clinical research services market size, by region, 2018-2024 (USD Million)
TABLE 29 Phase I market size, by region, 2013-2017 (USD Million)
TABLE 30 Phase I market size, by region, 2018-2024 (USD Million)
TABLE 31 Phase II market size, by region, 2013-2017 (USD Million)
TABLE 32 Phase II market size, by region, 2018-2024 (USD Million)
TABLE 33 Phase III market size, by region, 2013-2017 (USD Million)
TABLE 34 Phase III market size, by region, 2018-2024 (USD Million)
TABLE 35 Phase IV market size, by region, 2013-2017 (USD Million)
TABLE 36 Phase IV market size, by region, 2018-2024 (USD Million)
TABLE 37 Laboratory services market size, by region, 2013-2017 (USD Million)
TABLE 38 Laboratory services market size, by region, 2018-2024 (USD Million)
TABLE 39 Bioanalytical testing services market size, by region, 2013-2017 (USD Million)
TABLE 40 Bioanalytical testing services market size, by region, 2018-2024 (USD Million)
TABLE 41 Analytical testing services market size, by region, 2013-2017 (USD Million)
TABLE 42 Analytical testing services market size, by region, 2018-2024 (USD Million)
TABLE 43 Physical characterization market size, by region, 2013-2017 (USD Million)
TABLE 44 Physical characterization market size, by region, 2018-2024 (USD Million)
TABLE 45 Raw material testing market size, by region, 2013-2017 (USD Million)
TABLE 46 Raw material testing market size, by region, 2018-2024 (USD Million)
TABLE 47 Batch release testing market size, by region, 2013-2017 (USD Million)
TABLE 48 Batch release testing market size, by region, 2018-2024 (USD Million)
TABLE 49 Stability testing market size, by region, 2013-2017 (USD Million)
TABLE 50 Stability testing market size, by region, 2018-2024 (USD Million)
TABLE 51 Others market size, by region, 2013-2017 (USD Million)
TABLE 52 Others market size, by region, 2018-2024 (USD Million)
TABLE 53 Consulting services market size, by region, 2013-2017 (USD Million)
TABLE 54 Consulting services market size, by region, 2018-2024 (USD Million)
TABLE 55 Oncology market size, by region, 2013-2017 (USD Million)
TABLE 56 Oncology market size, by region, 2018-2024 (USD Million)
TABLE 57 Clinical pharmacology market size, by region, 2013-2017 (USD Million)
TABLE 58 Clinical pharmacology market size, by region, 2018-2024 (USD Million)
TABLE 59 Cardiology market size, by region, 2013-2017 (USD Million)
TABLE 60 Cardiology market size, by region, 2018-2024 (USD Million)
TABLE 61 Infectious disease market size, by region, 2013-2017 (USD Million)
TABLE 62 Infectious disease market size, by region, 2018-2024 (USD Million)
TABLE 63 Neurology market size, by region, 2013-2017 (USD Million)
TABLE 64 Neurology market size, by region, 2018-2024 (USD Million)
TABLE 65 Gastroenterology & hepatology market size, by region, 2013-2017 (USD Million)
TABLE 66 Gastroenterology & hepatology market size, by region, 2018-2024 (USD Million)
TABLE 67 Ophthalmology market size, by region, 2013-2017 (USD Million)
TABLE 68 Ophthalmology market size, by region, 2018-2024 (USD Million)
TABLE 69 Others market size, by region, 2013-2017 (USD Million)
TABLE 70 Others market size, by region, 2018-2024 (USD Million)
TABLE 71 Pharmaceutical & biopharmaceutical companies market size, by region, 2013-2017 (USD Mn)
TABLE 72 Pharmaceutical & biopharmaceutical companies market size, by region, 2018-2024 (USD Mn)
TABLE 73 Medical device companies market size, by region, 2013-2017 (USD Million)
TABLE 74 Medical device companies market size, by region, 2018-2024 (USD Million)
TABLE 75 Academic institutes market size, by region, 2013-2017 (USD Million)
TABLE 76 Academic institutes market size, by region, 2018-2024 (USD Million)
TABLE 77 North America CRO market size, by country, 2013-2017 (USD Million)
TABLE 78 North America CRO market size, by country, 2018-2024 (USD Million)
TABLE 79 North America CRO market size, by service type, 2013-2017 (USD Million)
TABLE 80 North America CRO market size, by service type, 2018-2024 (USD Million)
TABLE 81 North America CRO market size, by early phase development services, 2013-2017 (USD Mn)
TABLE 82 North America CRO market size, by early phase development services, 2018-2024 (USD Mn)
TABLE 83 North America CRO market size, by pre-clinical services, 2013-2017 (USD Million)
TABLE 84 North America CRO market size, by pre-clinical services, 2018-2024 (USD Million)
TABLE 85 North America CRO market size, by clinical research services, 2013-2017 (USD Million)
TABLE 86 North America CRO market size, by clinical research services, 2018-2024 (USD Million)
TABLE 87 North America CRO market size, by laboratory services, 2013-2017 (USD Million)
TABLE 88 North America CRO market size, by laboratory services, 2018-2024 (USD Million)
TABLE 89 North America CRO market size, by analytical testing services, 2013-2017 (USD Million)
TABLE 90 North America CRO market size, by analytical testing services, 2018-2024 (USD Million)
TABLE 91 North America CRO market size, by therapeutic area, 2013-2017 (USD Million)
TABLE 92 North America CRO market size, by therapeutic area, 2018-2024 (USD Million)
TABLE 93 North America CRO market size, by end-use, 2013-2017 (USD Million)
TABLE 94 North America CRO market size, by end-use, 2018-2024 (USD Million)
TABLE 95 U.S. CRO market size, by service type, 2013-2017 (USD Million)
TABLE 96 U.S. CRO market size, by service type, 2018-2024 (USD Million)
TABLE 97 U.S. CRO market size, by early phase development services, 2013-2017 (USD Million)
TABLE 98 U.S. CRO market size, by early phase development services, 2018-2024 (USD Million)
TABLE 99 U.S. CRO market size, by pre-clinical services, 2013-2017 (USD Million)
TABLE 100 U.S. CRO market size, by pre-clinical services, 2018-2024 (USD Million)
TABLE 101 U.S. CRO market size, by clinical research services, 2013-2017 (USD Million)
TABLE 102 U.S. CRO market size, by clinical research services, 2018-2024 (USD Million)
TABLE 103 U.S. CRO market size, by laboratory services, 2013-2017 (USD Million)
TABLE 104 U.S. CRO market size, by laboratory services, 2018-2024 (USD Million)
TABLE 105 U.S. CRO market size, by analytical testing services, 2013-2017 (USD Million)
TABLE 106 U.S. CRO market size, by analytical testing services, 2018-2024 (USD Million)
TABLE 107 U.S. CRO market size, by therapeutic area, 2013-2017 (USD Million)
TABLE 108 U.S. CRO market size, by therapeutic area, 2018-2024 (USD Million)
TABLE 109 U.S. CRO market size, by end-use, 2013-2017 (USD Million)
TABLE 110 U.S. CRO market size, by end-use, 2018-2024 (USD Million)
TABLE 111 Canada CRO market size, by service type, 2013-2017 (USD Million)
TABLE 112 Canada CRO market size, by service type, 2018-2024 (USD Million)
TABLE 113 Canada CRO market size, by early phase development services, 2013-2017 (USD Million)
TABLE 114 Canada CRO market size, by early phase development services, 2018-2024 (USD Million)
TABLE 115 Canada CRO market size, by pre-clinical services, 2013-2017 (USD Million)
TABLE 116 Canada CRO market size, by pre-clinical services, 2018-2024 (USD Million)
TABLE 117 Canada CRO market size, by clinical research services, 2013-2017 (USD Million)
TABLE 118 Canada CRO market size, by clinical research services, 2018-2024 (USD Million)
TABLE 119 Canada CRO market size, by laboratory services, 2013-2017 (USD Million)
TABLE 120 Canada CRO market size, by laboratory services, 2018-2024 (USD Million)
TABLE 121 Canada CRO market size, by analytical testing services, 2013-2017 (USD Million)
TABLE 122 Canada CRO market size, by analytical testing services, 2018-2024 (USD Million)
TABLE 123 Canada CRO market size, by therapeutic area, 2013-2017 (USD Million)
TABLE 124 Canada CRO market size, by therapeutic area, 2018-2024 (USD Million)
TABLE 125 Canada CRO market size, by end-use, 2013-2017 (USD Million)
TABLE 126 Canada CRO market size, by end-use, 2018-2024 (USD Million)
TABLE 127 Europe CRO market size, by country, 2013-2017 (USD Million)
TABLE 128 Europe CRO market size, by country, 2018-2024 (USD Million)
TABLE 129 Europe CRO market size, by service type, 2013-2017 (USD Million)
TABLE 130 Europe CRO market size, by service type, 2018-2024 (USD Million)
TABLE 131 Europe CRO market size, by early phase development services, 2013-2017 (USD Million)
TABLE 132 Europe CRO market size, by early phase development services, 2018-2024 (USD Million)
TABLE 133 Europe CRO market size, by pre-clinical services, 2013-2017 (USD Million)
TABLE 134 Europe CRO market size, by pre-clinical services, 2018-2024 (USD Million)
TABLE 135 Europe CRO market size, by clinical research services, 2013-2017 (USD Million)
TABLE 136 Europe CRO market size, by clinical research services, 2018-2024 (USD Million)
TABLE 137 Europe CRO market size, by laboratory services, 2013-2017 (USD Million)
TABLE 138 Europe CRO market size, by laboratory services, 2018-2024 (USD Million)
TABLE 139 Europe CRO market size, by analytical testing services, 2013-2017 (USD Million)
TABLE 140 Europe CRO market size, by analytical testing services, 2018-2024 (USD Million)
TABLE 141 Europe CRO market size, by therapeutic area, 2013-2017 (USD Million)
TABLE 142 Europe CRO market size, by therapeutic area, 2018-2024 (USD Million)
TABLE 143 Europe CRO market size, by end-use, 2013-2017 (USD Million)
TABLE 144 Europe CRO market size, by end-use, 2018-2024 (USD Million)
TABLE 145 Germany CRO market size, by service type, 2013-2017 (USD Million)
TABLE 146 Germany CRO market size, by service type, 2018-2024 (USD Million)
TABLE 147 Germany CRO market size, by early phase development services, 2013-2017 (USD Million)
TABLE 148 Germany CRO market size, by early phase development services, 2018-2024 (USD Million)
TABLE 149 Germany CRO market size, by pre-clinical services, 2013-2017 (USD Million)
TABLE 150 Germany CRO market size, by pre-clinical services, 2018-2024 (USD Million)
TABLE 151 Germany CRO market size, by clinical research services, 2013-2017 (USD Million)
TABLE 152 Germany CRO market size, by clinical research services, 2018-2024 (USD Million)
TABLE 153 Germany CRO market size, by laboratory services, 2013-2017 (USD Million)
TABLE 154 Germany CRO market size, by laboratory services, 2018-2024 (USD Million)
TABLE 155 Germany CRO market size, by analytical testing services, 2013-2017 (USD Million)
TABLE 156 Germany CRO market size, by analytical testing services, 2018-2024 (USD Million)
TABLE 157 Germany CRO market size, by therapeutic area, 2013-2017 (USD Million

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report